PartsTable TECHNICAL DATA SHEET
JULY 2026Technical Data Sheet

NDC69238-1838-07Levothyroxine Sodium Tablets

Amneal Pharmaceuticals of New York, Llc · NSN 6505-01-153-3338 · FSC 6505 · No Item Name Available
Verified by PartsTable
NSN 6505-01-153-3338 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-153-3338. Primary manufacturer part number: NDC69238-1838-07.
Features
  • Levothyroxine Sodium Tablets — FSC 6505
  • Primary Container Type: BOTTLE
  • Active Medicament Medicinal Strength: 0.150 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Administration: ORAL
  • Primary Container Content Quantity: 1000.000 TABLETS
  • 4 verified cross-references
  • Primary manufacturer: Amneal Pharmaceuticals of New York, Llc
Applications
  • Industrial maintenance and repair
  • Government and military logistics
  • Equipment overhaul and refurbishment
General Description

The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-153-3338, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Amneal Pharmaceuticals of New York, Llc. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 4 commercial cross-references from 3 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.

Technical Specifications
ParameterValue
NSN6505-01-153-3338
Primary Part NumberNDC69238-1838-07
Item NameLevothyroxine Sodium Tablets
FSC / FSG6505 / 65 — No Item Name Available
ManufacturerAmneal Pharmaceuticals of New York, Llc
StatusACTIVE
Primary Container TypeBOTTLE
Active Medicament Medicinal Strength0.150 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
Medical Designation and GradeUNITED STATES PHARMACOPEIA
AdministrationORAL
Primary Container Content Quantity1000.000 TABLETS
Lifecycle & Compliance
Acquisition StatusACTIVE
HAZMATNo
Unit of IssueBT
Verified Substitutes 12
6505-00-915-1630NDC00048-1140-03 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbott Laboratories Inc. Div Hospital Products Division
6505-00-990-2021 INTERCHANGEABLE
Levothyroxine Sodium Tablets
6505-01-042-9260NDC00074-6624-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-094-1636NDC00048-1040-05 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-099-9794NDC00074-4341-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Inc
6505-01-178-3941NDC00048-1090-13 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-212-77183P1095 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-290-8735NDC00074-4552-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-323-4605NDC00074-7068-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-351-0918NDC00048-1020-03 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbott Laboratories Inc. Div Hospital Products Division
Cross-Reference Index
Part NumberManufacturer
NDC69238-1838-07 PRIMARY Amneal Pharmaceuticals of New York, Llc (USA)
NDC00074-7069-19 Abbvie Us Llc (USA)
NDC00378-1815-10 PRIMARY Mylan Pharmaceuticals Inc (USA)
SYNTHROID Abbvie Us Llc (USA)
Related Parts
6505-00-915-1630INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1140-03
6505-00-990-2021INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
6505-01-042-9260INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-6624-19
6505-01-094-1636INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1040-05
6505-01-099-9794INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-4341-19
6505-01-178-3941INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1090-13
6505-01-212-7718INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
3P1095
6505-01-290-8735INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-4552-19
6505-01-323-4605INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-7068-19
6505-01-351-0918INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1020-03
6505-01-366-0962INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-5182-19
6505-01-596-5245INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-4552-90

Frequently Asked Questions

What is NSN 6505-01-153-3338?

NSN 6505-01-153-3338 is a Levothyroxine Sodium Tablets, manufactured by Amneal Pharmaceuticals of New York, Llc, classified under FSC 6505 (No Item Name Available). Status: active.

What are the part numbers for NSN 6505-01-153-3338?

NSN 6505-01-153-3338 has 4 cross-referenced part numbers: NDC69238-1838-07 (Amneal Pharmaceuticals of New York, Llc), NDC00074-7069-19 (Abbvie Us Llc), NDC00378-1815-10 (Mylan Pharmaceuticals Inc), SYNTHROID (Abbvie Us Llc).

What NSN replaces 6505-01-153-3338?

There are 12 known substitutes for 6505-01-153-3338: 6505-00-915-1630, 6505-00-990-2021, 6505-01-042-9260 and 9 more. Verify interchangeability with system specifications before substitution.

What are the specifications of NDC69238-1838-07?

Key specifications for NDC69238-1838-07: Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 0.150 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Part Name Assigned by Controlling Agency: LEVOTHYROXINE SODIUM TABLETS USP 0.150MG 1000S BT. 6 total characteristics are documented in the Federal Logistics Information System.

Validated with multiple authoritative sources, including Government, OEM, and Certified sources.
PartsTable Design LLC · partstable.com